Ignite Creation Date:
2025-12-24 @ 7:23 PM
Ignite Modification Date:
2026-02-23 @ 8:08 PM
Study NCT ID:
NCT02489903
Status:
COMPLETED
Last Update Posted:
2025-03-17
First Post:
2015-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
Sponsor:
EpicentRx, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-12-06
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-29
First Submit QC Date:
None
Study First Post Date:
2015-07-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-07-30
Results First Submit QC Date:
None
Results First Post Date:
2025-03-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-26
Last Update Post Date:
2025-03-17
Last Update Post Date Type:
ACTUAL